|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2002;73:346-347
© 2002 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Nedlands, Perth, W. Australia 6009, Australia
To the Editor
I believe Barron and colleagues [1] are to be congratulated on an excellent study relating to how a latissimus dorsi (LD) muscle should be managed best if it is to produce optimal performance as a transformed, fatigue resistant, skeletal muscle used as a viable biological assist device. Both senior authors, Pepper and Salmons [1] previously added substantially to the advancement of knowledge in this field. Importantly, by a novel preconditioning program that is radically different to what human cardiomyoplasty (CMP) patients had to their respective LD,
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |